跳至主要内容
临床试验/NCT07784296
NCT07784296招募中不适用

A Multicenter, Prospective, Non-interventional, Observational Study to Evaluate Effectiveness and Safety of Sequential Triple Combination Therapy (Amlodipine/Losartan/Chlorthalidone) in Korean Patients With Hypertension

Hanmi Pharmaceutical Company Limited1 个研究点 分布在 1 个国家目标入组 3,500 人开始时间: 2026年3月19日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
3,500
试验地点
1
主要终点
The change in Systolic Blood Pressure (SBP) relative to baseline

研究概览

简要总结

A multicenter, prospective, non-interventional, observational study to evaluate effectiveness and safety of sequential triple combination therapy (amlodipine/losartan/chlorthalidone) in Korean patients with hypertension

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Korean patients aged 19 years or older diagnosed with hypertension
  • Individuals newly diagnosed with hypertension or currently taking a single antihypertensive drug
  • Individuals for whom administration of Amoprel tablets has been determined based on the researcher's medical judgment
  • Individuals who have heard an explanation of this study and have voluntarily given written consent to participate in the study

排除标准

  • Individuals falling under the contraindications listed in the precautions for use of Amoprel Tab. or Amozartan Plus Tab.
  • Pregnant women, women who may be pregnant, and nursing mothers
  • Individuals currently participating in an interventional study
  • Individuals deemed unsuitable for participation in this study by the researcher for other reasons

结局指标

主要结局

The change in Systolic Blood Pressure (SBP) relative to baseline

时间窗: the 6-month time

次要结局

  • effectiveness of sequential triple combination therapy (amlodipine/losartan/chlorthalidone)(2, 4, 6 months)
  • Prescription patterns of a triple-therapy-based stepwise treatment strategy(2, 4, 6 months)
  • safety of sequential triple combination therapy (amlodipine/losartan/chlorthalidone)(2, 4 , 6 months)

研究者

发起方
Hanmi Pharmaceutical Company Limited
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验